I. V. Bayoglu Et Al. , "Prognostic value of mesothelin expression in patients with triple negative and HER2-positive breast cancers," BIOMEDICINE & PHARMACOTHERAPY , vol.70, pp.190-195, 2015
Bayoglu, I. V. Et Al. 2015. Prognostic value of mesothelin expression in patients with triple negative and HER2-positive breast cancers. BIOMEDICINE & PHARMACOTHERAPY , vol.70 , 190-195.
Bayoglu, I. V., Kucukzeybek, B. B., Kucukzeybek, Y., Varol, U., Yildiz, İ., Alacacioglu, A., ... Akyol, M.(2015). Prognostic value of mesothelin expression in patients with triple negative and HER2-positive breast cancers. BIOMEDICINE & PHARMACOTHERAPY , vol.70, 190-195.
Bayoglu, Ibrahim Et Al. "Prognostic value of mesothelin expression in patients with triple negative and HER2-positive breast cancers," BIOMEDICINE & PHARMACOTHERAPY , vol.70, 190-195, 2015
Bayoglu, Ibrahim V. Et Al. "Prognostic value of mesothelin expression in patients with triple negative and HER2-positive breast cancers." BIOMEDICINE & PHARMACOTHERAPY , vol.70, pp.190-195, 2015
Bayoglu, I. V. Et Al. (2015) . "Prognostic value of mesothelin expression in patients with triple negative and HER2-positive breast cancers." BIOMEDICINE & PHARMACOTHERAPY , vol.70, pp.190-195.
@article{article, author={Ibrahim Vedat Bayoglu Et Al. }, title={Prognostic value of mesothelin expression in patients with triple negative and HER2-positive breast cancers}, journal={BIOMEDICINE & PHARMACOTHERAPY}, year=2015, pages={190-195} }